Clarity Medical Group Holding Limited (Clarity Medical) submitted its Monthly Return for Equity Issuer for the period ended 30 April 2026, highlighting a month of capital stability with no share issuances, cancellations or treasury-share movements.
Authorised and Issued Share Capital • Authorised share capital remained at 5.00 billion ordinary shares with a par value of HKD 0.01, equivalent to HKD 50.00 million. • Issued share count was unchanged at 536.33 million ordinary shares. • No treasury shares were held, issued or cancelled during the month.
Public Float Status • Management certified that the company continued to meet the Main Board’s minimum 25% public-float requirement as at 30 April 2026.
Equity Incentive Arrangements • Pre-IPO Share Option Scheme: No outstanding, granted or exercised options; no shares reserved. • Share Award Plan (approved 23 November 2022): Up to 43.97 million shares remain available for future awards; no awards were granted, vested or transferred in April.
Capital Movements Summary • Net change in issued shares: 0. • Net change in treasury shares: 0.
The April filing affirms Clarity Medical’s unchanged share capital and adherence to Hong Kong Listing Rules, providing shareholders with clarity on the company’s equity position.
Comments